Infectious Disease Research
The University of Oxford supports clinical research in infectious diseases with a focus on monkeypox virus disease and pneumonia, addressing both emerging viral infection and severe respiratory illness.
- Monkeypox virus disease
- Pneumonia
- Viral infection
- Respiratory disease
Its trial portfolio includes studies of clinical outcomes in patients with mpox and investigations in hospital-based care for patients with pneumonia.
Hospital Medicine and Acute Care
Clinical activity includes research on outcomes relevant to hospitalised patients, with attention to mortality and time to discharge in acute illness settings.
- Mortality
- Time to discharge
- Hospital care
- Acute illness
These studies reflect an interest in clinical endpoints that are directly relevant to inpatient management and recovery.
Antiviral and Therapeutic Outcomes
Research funded by the sponsor examines outcomes in patients treated and not treated with tecovirimat and other antiviral drugs, with emphasis on treatment-related clinical course in mpox.
- Tecovirimat
- Antiviral therapy
- Treatment outcomes
- Clinical course
The therapeutic focus is centred on understanding how antiviral management relates to patient outcomes in monkeypox virus disease.
Multinational Clinical Collaboration
The sponsor’s research spans 11 countries through a network of 122 collaborating research sites, supporting coordinated study of infectious disease outcomes across diverse clinical settings.
- International research sites
- Collaborative studies
- Cross-country recruitment
- Clinical outcome assessment
This footprint supports work in both pneumonia and mpox across multiple healthcare environments.
